As of 2026-10-02, the Relative Valuation of Chinook Therapeutics Inc (KDNY) is (70.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 40.39 USD, the upside of Chinook Therapeutics Inc based on Relative Valuation is -275.5%.
The range of the Relative Valuation is (60.90) - (85.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 25.1x | 21.5x |
| Forward P/E multiples | 14.7x - 25.3x | 20.0x |
| Fair Price | (60.90) - (85.87) | (70.90) |
| Upside | -250.8% - -312.6% | -275.5% |
| Date | P/E |